Improving the filterability and solid density of ranitidine hydrochloride Form 1

Journal of Pharmaceutical Sciences

Volumn 93, Issue 7, 2004, Pages 1692-1700

  Mirmehrabi, Mahmoud ^a   Rohani, Sohrab ^a   Murthy, K S Keshava ^b   Radatus, Bruno ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Brantford Chemicals Inc   (Canada)

Author keywords

Filterability; Form 1; Quality improvement; Ranitidine hydrochloride; Solid bulk density

Indexed keywords

ACID; BASE; RANITIDINE; SOLVENT;

ARTICLE; BULK DENSITY; CRYSTALLIZATION; DRUG QUALITY; FILTRATION; HIGH TEMPERATURE; PH; QUALITY CONTROL; ROOM TEMPERATURE; SOLID BULK DENSITY; TEMPERATURE DEPENDENCE; VISCOSITY;

EID: 3042686291     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20074     Document Type: Article

References (17)

1. Canadian pharmacists association. 2000. Ranitidine HCl. In: Compendium of pharmaceuticals and specialties, 35th ed. Toronto: Webcom Limited, pp 1772-1774.
2. Hohnjec M, Kuftinec J, Malnar M. 1986. Ranitidine. In: Flory K, editor. Analytical profiles of drug substances. New York: Academic Press, pp 533-561.
3. Dumanovic D, Juranic I, Dzeletovic D, Vasic VM, Jovanovic J. 1997. Protolytic constants of nizatidine, ranitidine and N,N′-dimethyl-2-nitro- 1,1-ethenediamine, spectrophotometric and theoretical investigation. J Pharm Biomed Anal 15:1667-1678.
4. Cholerton TJ, Hunt JH, Klinkert G, Smith MM. 1984. Spectroscopic studies on ranitidine: Its structure and the influence of temperature and pH. J Chem Soc Perkin Trans 2:1761-1766.
5. Yoo SH. 1997. Amine acid salt compounds and process for the production thereof. US patent 5,686,588.
6. Madan T. 1994. Preparation and characterization of ranitidine-HCl crystals. Drug Dev Ind Pharm 20:1571-1588.
7. Price BJ, Clitherow JW, Bradshaw J. 1978. Aminoalkyl furan derivatives. US patent 4,128,658.
8. Crookes DJ. 1985. Aminoalkyl furan derivatives. US patent 4,521,431.
9. Khanna JM, Kumar N, Khera B, Khanna M. 1997. Process for the manufacture of form 1 ranitidine hydrochloride. US patent 5,621,120.
10. Murthy K, Radatus BK, Sidhu KPS. 1995. reissued 2002. Process for production of an improved form of form 1 ranitidine hydrochloride having improved filtration and drying characteristics. Canadian patent 2120874.
11. Ngooi TK, McGolrick JD, Antczak C, Tindall JLA. 1994. Preparation of form 1 ranitidine hydrochloride. US patent 5,338,871.
12. Ngooi TK, Antczak C, Tindall JLA, McGolrick JD. 1998. Preparation of form 1 ranitidine hydrochloride. Canadian patent 2099530.
13. Schickaneder H, Nikolopoulos A. 1997. Process for preparing form 1 ranitidine hydrochloride. US patent 5,663,381.
14. Mirmehrabi M, Rohani S, Murthy KSK, Radatus B. 2004. Characterization of tautomeric forms of ranitidine hydrochloride: Thermal analysis, solid-state NMR, X-ray. J Cryst Growth 260:517-526.
15. Mirmehrabi M, Rohani S, Murthy KSK, Radatus B. 2003. Solubility, dissolution rate and phase transition studies of ranitidine hydrochloride tautomeric forms. Int J Pharm, submitted.
16. McCabe WL, Smith JC. 1976. Unit operations of chemical engineering, 3rd ed. New York: McGraw Hill, pp 932-938.
17. ICH topic Q3C. 1997. Residual solvent. http://www.emea.eu.int/pdfs/human/ ich/028395en.pdf.